Ensure FDA compliance, manage signals effectively, and reduce time-to-market with our Expert Drug Safety & Compliance Support for Life Sciences Companies
ICSR
Aggregate Reports
RMP
ADCO/AASR
At DDReg, we specialize in customized pharmacovigilance consulting services tailored for pharmaceutical, biotech, and life sciences organizations in the United States.
Comprehensive case intake, processing, medical review, and regulatory submission for post-marketing cases.
Provision of Local QPPV and Deputy QPPV to ensure 24/7 compliance oversight.
Proactive signal detection, validation, and assessment to identify risks early using advanced safety databases.
Mock inspections, gap analysis, and system audits to prepare you for FDA/EMA inspections.
Comprehensive global and local literature screening to identify safety signals and ICSRs with high precision.
Expert preparation and submission of PSURs, PBRERs, and PADERs ensuring data integrity and medical accuracy.
To establish locally compliant QPPV presence across 11 markets within 30 days, build an inspection-ready pharmacovigilance framework integrated with the client’s global PV systems
Read Full Study →To ensure compliance, a systematic PV audit identified non-compliances, providing practical steps for inspection-readiness aligned with global pharmacovigilance expectations and standards.
Read Full Study →A MENA regulator addressed critical PV system gaps to boost drug safety monitoring for its product portfolio across the region, ensuring enhanced oversight and compliance.
Read Full Study →"DDReg’s strong subject matter expertise has been a great support to our team, helping us ensure timely and accurate case submissions"
We conduct an initial audit of your current PV system to identify regulatory gaps and safety needs.
Deployment of QPPV, safety databases, and custom SOPs tailored to USA, EU, MENA, etc regulations.
Ongoing ICSR processing, signal detection, and aggregate reporting to ensure inspection readiness 24/7.